ISSN: 2228-5881 eISSN: 2251-7308

Submit Your Paper Instructions for Authors Aims and Scope Editorial Board Editorial Policies Publication Ethics Indexing Info About APB & Contacts Indexing and Abstracting Articles In Press Archive

Journal Info:

Freq.: Quarterly

eISSN: 2251-7308
pISSN: 2228-5881

Permission: CC By

Platinum Open Access

(no submission or publication fees)

Abstracting and Indexing

PubMed Central, Pubmed,

Emerging Sources Citation Index

Scopus, Google Scholar,

EMBASE/Excerpta Medica

EBSCOhost; CAS: DOAJ

2024, Vol 14, No. 4

Advanced Pharmaceutical Bulletin (APB) is a peer-reviewed multidisciplinary open access journal, covering a wide range of various integrative fields with Pharmaceutical sciences.
APB is the official journal of Drug Applied Research Center and Faculty of Pharmacy, published by TUOMS PRESS, Tabriz University of Medical Sciences.

Publication Advantages in Advanced Pharmaceutical Bulletin are:

Free of charge publication for all types of articles
Fast and constructive peer review
Easy and quick online submission of manuscripts
Author friendly review
Rapid publication by means of running issue concept, which gives authors the benefit of 'No Waiting Time' for the officially accepted manuscripts
Free publication of color images
Worldwide visibility of papers (Open Access Journal)

Original Research

1. Novel PH Sensitive NanocarrierAgents Based on Citric Acid DendrimersContaining Conjugated β-Cyclodextrins

Hassan Namazi*, Yousef Toomari Hamrahloo

Adv Pharm Bull. 2011;1(1): 40-47. doi: 10.5681/apb.2011.006

PMCID: PMC3850000 PMID: 24312755 Scopus ID: 84868291748

Article

PDF

XML

Cited By:

Research Article

2. Conjugation of Gentamicin to Polyamidoamine Dendrimers Improved Anti-bacterial Properties against Pseudomonas aeruginosa

Hamed Sheykhloo , Morteza Milani, Farhood Najafi, Farhad Bani* , Amir Zarebkohan*

Adv Pharm Bull. 2021;11(4): 675-683. doi: 10.34172/apb.2021.076

PMCID: PMC8642794 PMID: 34888214 Scopus ID: 85117197771

Article

PDF

Full Text

XML

Cited By:

Research Article

3. Comparative Evaluation of Lipofectamine and Dendrimer for Transfection of Short RNA Into Human T47D and MCF-10A Cell Lines

Zohreh Jahanafrooz , Behnaz Bakhshandeh* , Erfan Shirzadi

Adv Pharm Bull. 2023;13(2): 385-392. doi: 10.34172/apb.2023.022

PMCID: PMC10278214 PMID: 37342383

Article

PDF

Suppl 1

Full Text

XML

Cited By:

Research Article

4. Discovery of a Novel Dual Targeting Peptide for Human Glioma: From In Silico Simulation to Acting as Targeting Ligand

Negar Sedghi Aminabad , Yousef Saeedi, Jamal Adiban, Mahdieh Nemati, Donya Shaterabadi, Farhood Najafi, Reza Rahbarghazi, Mehdi Talebi, Amir Zarebkohan*

Adv Pharm Bull. 2024;14(2): 453-468. doi: 10.34172/apb.2024.033

PMCID: PMC11347739 PMID: 39206396

Article

PDF

Suppl 1

Full Text

XML

Cited By:

Research Article

5. Dual-stage Acting Dendrimeric Nanoparticle for Deepened Chemotherapeutic Drug Delivery to Tumor Cells

Mohammad Shahpouri , Mohammad Amin Adili-Aghdam, Hossein Mahmudi, Saeedeh Ghiasvand, Hamed Dadashi, Aysan Salemi, Sajjad Alimohammadvand, Leila Roshangar, Abolfazl Barzegari, Mehdi Jaymand*, Rana Jahanban-Esfahlan*

Adv Pharm Bull. 2024;14(3): 634-645. doi: 10.34172/apb.2024.054

PMCID: PMC11530877 PMID: 39494252

Article

PDF

Full Text

XML

Cited By: